Citation: Jh. Yim et al., Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: Resistance to endogenous IFN-gamma, J INTERF CY, 19(7), 1999, pp. 723-729
Authors:
Mutch, MG
Dilley, WG
Sanjurjo, F
DeBenedetti, MK
Doherty, GM
Wells, SA
Goodfellow, PJ
Lairmore, TC
Citation: Mg. Mutch et al., Germline mutations in the multiple endocrine neoplasia type 1 gene: Evidence for frequent splicing defects, HUM MUTAT, 13(3), 1999, pp. 175-185
Authors:
Roeher, HD",Perrier,"Doherty, GM
Mancino, AT
Shaha, AR
Borman, KR
Hurley, J
Citation: Gm. Roeher, Hd",perrier,"doherty et al., Classification and treatment of follicular thyroid neoplasms are discordant between and within medical specialties - Discussion, SURGERY, 126(6), 1999, pp. 1069-1069
Authors:
Nguyen, T
Naziruddin, B
Dintzis, S
Doherty, GM
Mohanakumar, T
Citation: T. Nguyen et al., Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes, INT J CANC, 81(4), 1999, pp. 607-615
Authors:
Yim, JH
Siegel, BA
DeBenedetti, MK
Norton, JA
Lairmore, TC
Doherty, GM
Citation: Jh. Yim et al., Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1, SURGERY, 124(6), 1998, pp. 1037-1042